Pressure BioSciences Completes Move to New Manufacturing Facility, Uniting R&D with Expanded UltraShear Equipment Development and Contract Manufacturing
Friday, February 16, 2024
Pressure BioSciences, Inc. (OTCQB: PBIO) celebrated a significant milestone today by consolidating its Boston area operations into a cutting-edge facility in Canton, MA. This move brings together all personnel under one roof, enhancing R&D capabilities, equipment development, and production services, with a focus on its patented Ultra Shear Technology (UltraShear™ or UST™) platform. The newly renovated facility in Canton will serve as a modern manufacturing hub.
Located strategically in Canton, MA, the new facility provides PBIO with a larger, more efficient space to continue its pioneering work in high-pressure nanotechnology, particularly with UltraShear technology. It is equipped with modern utilities and amenities, housing dedicated spaces for R&D, equipment production, formulation services, and product manufacturing. By consolidating R&D with other departments, PBIO aims to improve production efficiencies, reduce costs, and foster innovation in a collaborative setting.
Ken Micciche, PBIO’s Director of Business Development, expressed enthusiasm about the consolidation and expansion, highlighting its potential to accelerate development and production capabilities. He emphasized the company's commitment to delivering exceptional products and services, advancing high-pressure nanotechnology, and supporting growth, particularly in the direct-to-consumer sector through its subsidiary Uncle Bud’s Health & Wellness.
Source: globenewswire.com
